This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lalani, A. S.
Right arrow Articles by McFadden, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lalani, A. S.
Right arrow Articles by McFadden, G.

 Previous Article  |  Next Article 

J. Virol., 06 1997, 4356-4363, Vol 71, No. 6
Copyright © 1997, American Society for Microbiology

The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines

AS Lalani, K Graham, K Mossman, K Rajarathnam, I Clark-Lewis, D Kelvin and G McFadden
Department of Biochemistry, University of Alberta, Edmonton, Canada.

The myxoma virus T7 protein M-T7 is a functional soluble gamma interferon receptor homolog that has previously been shown to bind gamma interferon and inhibit its antiviral activities in a species- specific manner, but gene knockout analysis has suggested a further role for M-T7 in blocking leukocyte influx into infected lesions. We purified M-T7 to apparent homogeneity and showed that M-T7 is an N- linked glycoprotein that appears to be a stable homotrimer with a molecular mass of approximately 113 kDa in solution. M-T7, in addition to forming inhibitory complexes with rabbit gamma interferon, was also shown to bind to human interleukin-8, a prototypic member of the chemokine superfamily. Moreover, M-T7 was able to interact promiscuously with all members of the CXC, CC, and C chemokine subfamilies tested. Binding of human RANTES to M-T7 can be competed by rabbit gamma interferon and also by cold RANTES competitor with a 50% inhibitory concentration of 900 nM. Although M-T7 retains binding to a number of interleukin-8 N-terminal (ELR) deletion mutants, binding to mutants containing deletions in the C-terminal heparin-binding domain of interleukin-8 is abrogated. Furthermore, heparin effectively competes the interaction of M-T7 with the chemokine RANTES but not with rabbit gamma interferon. We propose that this novel M-T7 interaction with members of the chemokine superfamily may be facilitated through the conserved heparin-binding domains found in a wide spectrum of chemokines and that M-T7 may function by modulating chemokine- glycosaminoglycan interactions in virus-infected tissues.


This article has been cited by other articles:

  • Van de Walle, G. R., Kaufer, B. B., Chbab, N., Osterrieder, N. (2009). Analysis of the Herpesvirus Chemokine-binding Glycoprotein G Residues Essential for Chemokine Binding and Biological Activity. J. Biol. Chem. 284: 5968-5976 [Abstract] [Full Text]  
  • Nuara, A. A., Walter, L. J., Logsdon, N. J., Yoon, S. I., Jones, B. C., Schriewer, J. M., Buller, R. M., Walter, M. R. (2008). Structure and mechanism of IFN-{gamma} antagonism by an orthopoxvirus IFN-{gamma}-binding protein. Proc. Natl. Acad. Sci. USA 105: 1861-1866 [Abstract] [Full Text]  
  • Ruiz-Arguello, M. B., Smith, V. P., Campanella, G. S. V., Baleux, F., Arenzana-Seisdedos, F., Luster, A. D., Alcami, A. (2008). An Ectromelia Virus Protein That Interacts with Chemokines through Their Glycosaminoglycan Binding Domain. J. Virol. 82: 917-926 [Abstract] [Full Text]  
  • Frauenschuh, A., Power, C. A., Deruaz, M., Ferreira, B. R., Silva, J. S., Teixeira, M. M., Dias, J. M., Martin, T., Wells, T. N. C., Proudfoot, A. E. I. (2007). Molecular Cloning and Characterization of a Highly Selective Chemokine-binding Protein from the Tick Rhipicephalus sanguineus. J. Biol. Chem. 282: 27250-27258 [Abstract] [Full Text]  
  • Sakala, I. G., Chaudhri, G., Buller, R. M., Nuara, A. A., Bai, H., Chen, N., Karupiah, G. (2007). Poxvirus-Encoded Gamma Interferon Binding Protein Dampens the Host Immune Response to Infection. J. Virol. 81: 3346-3353 [Abstract] [Full Text]  
  • Werden, S. J., Barrett, J. W., Wang, G., Stanford, M. M., McFadden, G. (2007). M-T5, the Ankyrin Repeat, Host Range Protein of Myxoma Virus, Activates Akt and Can Be Functionally Replaced by Cellular PIKE-A. J. Virol. 81: 2340-2348 [Abstract] [Full Text]  
  • Nuara, A. A., Buller, R. M. L., Bai, H. (2007). Identification of residues in the ectromelia virus gamma interferon-binding protein involved in expanded species specificity. J. Gen. Virol. 88: 51-60 [Abstract] [Full Text]  
  • Nuara, A. A., Bai, H., Chen, N., Buller, R. M. L., Walter, M. R. (2006). The Unique C Termini of Orthopoxvirus Gamma Interferon Binding Proteins Are Essential for Ligand Binding. J. Virol. 80: 10675-10682 [Abstract] [Full Text]  
  • Zhang, L., DeRider, M., McCornack, M. A., Jao, S.-c., Isern, N., Ness, T., Moyer, R., LiWang, P. J. (2006). Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc. Natl. Acad. Sci. USA 103: 13985-13990 [Abstract] [Full Text]  
  • Arnold, P. L., Fremont, D. H. (2006). Structural determinants of chemokine binding by an ectromelia virus-encoded decoy receptor.. J. Virol. 80: 7439-7449 [Abstract] [Full Text]  
  • Wang, G., Barrett, J. W., Stanford, M., Werden, S. J., Johnston, J. B., Gao, X., Sun, M., Cheng, J. Q., McFadden, G. (2006). Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Proc. Natl. Acad. Sci. USA 103: 4640-4645 [Abstract] [Full Text]  
  • Singh, U. P., Singh, S., Ravichandran, P., Taub, D. D., Lillard, J. W. Jr. (2004). Viral Macrophage-Inflammatory Protein-II: A Viral Chemokine That Differentially Affects Adaptive Mucosal Immunity Compared with Its Mammalian Counterparts. J. Immunol. 173: 5509-5516 [Abstract] [Full Text]  
  • Lucas, A., McFadden, G. (2004). Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics. J. Immunol. 173: 4765-4774 [Abstract] [Full Text]  
  • Webb, L. M. C., Clark-Lewis, I., Alcami, A. (2003). The Gammaherpesvirus Chemokine Binding Protein Binds to the N Terminus of CXCL8. J. Virol. 77: 8588-8592 [Abstract] [Full Text]  
  • Johnston, J. B., McFadden, G. (2003). Poxvirus Immunomodulatory Strategies: Current Perspectives. J. Virol. 77: 6093-6100 [Full Text]  
  • Von der Thusen, J. H., Kuiper, J., Van Berkel, T. J. C., Biessen, E. A. L. (2003). Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential. Pharmacol. Rev. 55: 133-166 [Abstract] [Full Text]  
  • Lillard, J. W. Jr, Singh, U. P., Boyaka, P. N., Singh, S., Taub, D. D., McGhee, J. R. (2003). MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood 101: 807-814 [Abstract] [Full Text]  
  • Seet, B. T., McFadden, G. (2002). Viral chemokine-binding proteins. J. Leukoc. Biol. 72: 24-34 [Abstract] [Full Text]  
  • Beck, C. G., Studer, C., Zuber, J.-F., Demange, B. J., Manning, U., Urfer, R. (2001). The Viral CC Chemokine-binding Protein vCCI Inhibits Monocyte Chemoattractant Protein-1 Activity by Masking Its CCR2B-binding Site. J. Biol. Chem. 276: 43270-43276 [Abstract] [Full Text]  
  • O’Brien, W. J., Heimann, T., Tsao, L.-S., Seet, B. T., McFadden, G., Taylor, J. L. (2001). Regulation of Nitric Oxide Synthase 2 in Rabbit Corneal Cells. IOVS 42: 713-719 [Abstract] [Full Text]  
  • Verardi, P. H., Jones, L. A., Aziz, F. H., Ahmad, S., Yilma, T. D. (2001). Vaccinia Virus Vectors with an Inactivated Gamma Interferon Receptor Homolog Gene (B8R) Are Attenuated In Vivo without a Concomitant Reduction in Immunogenicity. J. Virol. 75: 11-18 [Abstract] [Full Text]  
  • Lillard, J. W. Jr., Boyaka, P. N., Taub, D. D., McGhee, J. R. (2001). RANTES Potentiates Antigen-Specific Mucosal Immune Responses. J. Immunol. 166: 162-169 [Abstract] [Full Text]  
  • van Berkel, V., Barrett, J., Tiffany, H. L., Fremont, D. H., Murphy, P. M., McFadden, G., Speck, S. H., Virgin, H. W. IV (2000). Identification of a Gammaherpesvirus Selective Chemokine Binding Protein That Inhibits Chemokine Action. J. Virol. 74: 6741-6747 [Abstract] [Full Text]  
  • Born, T. L., Morrison, L. A., Esteban, D. J., VandenBos, T., Thebeau, L. G., Chen, N., Spriggs, M. K., Sims, J. E., Buller, R. M. L. (2000). A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response. J. Immunol. 164: 3246-3254 [Abstract] [Full Text]  
  • Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000). International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacol. Rev. 52: 145-176 [Abstract] [Full Text]  
  • Deane, D., McInnes, C. J., Percival, A., Wood, A., Thomson, J., Lear, A., Gilray, J., Fleming, S., Mercer, A., Haig, D. (2000). Orf Virus Encodes a Novel Secreted Protein Inhibitor of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2. J. Virol. 74: 1313-1320 [Abstract] [Full Text]  
  • Dietz, M. (2000). Viral Cytokines. The Oncologist 5: 77-80 [Full Text]  
  • Lalani, A. S., Masters, J., Zeng, W., Barrett, J., Pannu, R., Everett, H., Arendt, C. W., McFadden, G. (1999). Use of Chemokine Receptors by Poxviruses. Science 286: 1968-1971 [Abstract] [Full Text]  
  • Camarda, G., Spinetti, G., Bernardini, G., Mair, C., Davis-Poynter, N., Capogrossi, M. C., Napolitano, M. (1999). The Equine Herpesvirus 2 E1 Open Reading Frame Encodes a Functional Chemokine Receptor. J. Virol. 73: 9843-9848 [Abstract] [Full Text]  
  • Turner, P. C., Sancho, M. C., Thoennes, S. R., Caputo, A., Bleackley, R. C., Moyer, R. W. (1999). Myxoma Virus Serp2 Is a Weak Inhibitor of Granzyme B and Interleukin-1beta -Converting Enzyme In Vitro and Unlike CrmA Cannot Block Apoptosis in Cowpox Virus-Infected Cells. J. Virol. 73: 6394-6404 [Abstract] [Full Text]  
  • Fleming, P., Davis-Poynter, N., Degli-Esposti, M., Densley, E., Papadimitriou, J., Shellam, G., Farrell, H. (1999). The Murine Cytomegalovirus Chemokine Homolog, m131/129, Is a Determinant of Viral Pathogenicity. J. Virol. 73: 6800-6809 [Abstract] [Full Text]  
  • MacDonald, M. R., Burney, M. W., Resnick, S. B., Virgin, H. W. IV (1999). Spliced mRNA Encoding the Murine Cytomegalovirus Chemokine Homolog Predicts a beta  Chemokine of Novel Structure. J. Virol. 73: 3682-3691 [Abstract] [Full Text]  
  • Damon, I., Murphy, P. M., Moss, B. (1998). Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc. Natl. Acad. Sci. USA 95: 6403-6407 [Abstract] [Full Text]  
  • Strockbine, L. D., Cohen, J. I., Farrah, T., Lyman, S. D., Wagener, F., DuBose, R. F., Armitage, R. J., Spriggs, M. K. (1998). The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor. J. Virol. 72: 4015-4021 [Abstract] [Full Text]  
  • Alcami, A., Symons, J. A., Collins, P. D., Williams, T. J., Smith, G. L. (1998). Blockade of Chemokine Activity by a Soluble Chemokine Binding Protein from Vaccinia Virus. J. Immunol. 160: 624-633 [Abstract] [Full Text]  
  • Seet, B. T., Barrett, J., Robichaud, J., Shilton, B., Singh, R., McFadden, G. (2001). Glycosaminoglycan Binding Properties of the Myxoma Virus CC-chemokine Inhibitor, M-T1. J. Biol. Chem. 276: 30504-30513 [Abstract] [Full Text]